Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Verrica Pharmaceuticals (VRCA) Change in Acquisitions & Divestments (2021 - 2022)

Historic Change in Acquisitions & Divestments for Verrica Pharmaceuticals (VRCA) over the last 2 years, with Q4 2022 value amounting to $7.0 million.

  • Verrica Pharmaceuticals' Change in Acquisitions & Divestments fell 5070.42% to $7.0 million in Q4 2022 from the same period last year, while for Sep 2023 it was $7.0 million, marking a year-over-year decrease of 8942.73%. This contributed to the annual value of $59.0 million for FY2022, which is 1448.12% down from last year.
  • Verrica Pharmaceuticals' Change in Acquisitions & Divestments amounted to $7.0 million in Q4 2022, which was down 5070.42% from $2.0 million recorded in Q3 2022.
  • Verrica Pharmaceuticals' Change in Acquisitions & Divestments' 5-year high stood at $47.5 million during Q1 2022, with a 5-year trough of $2.0 million in Q3 2022.